Boston ADA.

Diabetes medications will continue to rise, the cost of developing and introducing new medication is also on the rise. In terms of diabetes drugs, we have seen very large studies, trials and the lengthening cost money, which suggest larger than average development costs.

At a Meeting


BOSTON ADA Meeting

We are gathered to share cutting-edge research, treatment recommendation toward a better life for people with diabetes – in the long run a cure for diabetes.

In US 23 million people, children and adults, have diabetes.

The ADA Meeting started 75 years ago – so this year a year

BOSTON, MA — The IMPROVE-IT study, the large cardiovascular-outcomes trial that showed a clinical benefit to adding ezetimibe (Zetia, Merck/Schering Plough) to statin therapy in post–acute coronary syndrome (ACS) patients, is now published^[1].

First presented during the late-breaking

Värdebaserad uppföljning av diabetesvård – analys från framtagande av nya uppföljningssystem

Dawit Isaak, jornalist och författare, har suttit fängslad i 5000 dagar i sitt forn hemland Eritrea.

13 år, 8 månader och 2 veckor.

Utan en formell anklagelse. Utan att dom avkunnats.

Idag arrangeras bland andra städer en stor manifestation på Sergels Torg i Stockholm, dit arrangören ränkar med att

Nashville, Tennessee — The bihormonal "bionic pancreas" continues to perform well in clinical trials and could reach the US market by 2018.

In the opening plenary session here at the American Association of Clinical Endocrinologists' (AACE) 2015 Annual Scientific and Clinical Congress, the

A new study found that diabetes patients who took metformin had a lower risk of developing open-angle glaucoma.

"Should these findings be confirmed in other populations in prospective clinical trials, they may lead to novel treatments for this sight-threatening disease and offer new opportunities to

New evidence from continuous glucose monitoring data indicates that fat, protein, and glycemic index, may also have a major effect on postprandial glucose levels.

Researchers conducted a systematic review of biomedical databases MEDLINES, Embase, CINAHL, and the Cochrane Central Register of